| Literature DB >> 25083861 |
Aniko Vörös1, Roger Simm1, Leyla Slamti2, Matthew J McKay3, Ida K Hegna1, Christina Nielsen-LeRoux2, Karl A Hassan4, Ian T Paulsen4, Didier Lereclus5, Ole Andreas Økstad1, Mark P Molloy3, Anne-Brit Kolstø1.
Abstract
The aim of this study was to explore the role of SecDF in protein secretion in Bacillus cereus ATCC 14579 by in-depth characterization of a markerless secDF knock out mutant. Deletion of secDF resulted in pleiotropic effects characterized by a moderately slower growth rate, aberrant cell morphology, enhanced susceptibility to xenobiotics, reduced virulence and motility. Most toxins, including food poisoning-associated enterotoxins Nhe, Hbl, and cytotoxin K, as well as phospholipase C were less abundant in the secretome of the ΔsecDF mutant as determined by label-free mass spectrometry. Global transcriptome studies revealed profound transcriptional changes upon deletion of secDF indicating cell envelope stress. Interestingly, the addition of glucose enhanced the described phenotypes. This study shows that SecDF is an important part of the Sec-translocase mediating efficient secretion of virulence factors in the Gram-positive opportunistic pathogen B. cereus, and further supports the notion that B. cereus enterotoxins are secreted by the Sec-system.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25083861 PMCID: PMC4118872 DOI: 10.1371/journal.pone.0103326
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Growth characteristics of the ΔsecDF mutant in LB with and without glucose.
Growth of B. cereus ATCC 14579 (WT) and ΔsecDF mutant in A) LB (no glucose) and B) LBG (1% glucose) in shaking cultures at 30°C. The graphs show average OD600nm values with standard deviations of two independent cultures for each strain. C) light micrographs of cultures after 24 h growth. D) growth of WT (left) and the ΔsecDF mutant (right) at 30°C for 16 h on LB and LBG agar. All pictures represent results of at least two independent experiments.
Figure 2Diminished motility of the ΔsecDF mutant.
A) Motility of the ΔsecDF mutant compared to the wild type strain on 0.3% LB only —, or LB agar plates supplemented with: gluc, 0.4% glucose; malt, 1% maltose; sucr, 1% sucrose; xyl, 1% xylose; sorb, 1% sorbitol; galac, 1% galactose; tw, 0.02% Tween80, tw+gluc, 0.02% Tween80 and 0.4% glucose. The graph shows averages of four to ten independent experiments, error bars represent standard errors and an unpaired Students t-test with two-tailed distribution was performed between wild type and ΔsecDF mutant (all conditions P<0.05). A nonparametric ANOVA with Dunn's multiple comparison post hoc test was performed for “LB only” and each of the conditions using additives (*P<0.01; **P<0.001). No movement of the ΔsecDF mutant was recorded in LB+sucrose in four experiments. B) Comparison of motility on 0.7% LBG after 7 h incubation at 30°C; top: wild type; bottom: ΔsecDF mutant. C) AFM amplitude images representative of two independent experiments of cells grown in LBG for 4 h show the grade of flagellation and secretion of putative membrane vesicles. Bars: 1 µm in whole cell images; 0.2 µm in the wild type detail image indicating putative vesicles (arrows).
Figure 3Decreased protein secretion in the ΔsecDF mutant.
The ΔsecDF mutant secretes less protein than the B. cereus ATCC 14579 wild type strain. Equal volumes of normalized and 40-fold concentrated supernatants collected after 3 h (exponential phase), 4 h (transition phase) and 6 h (stationary phase) of growth were applied on 4–20% gradient SDS-PAGE gels and silver stained. The gel represents results of two independent experiments.
Proteins found in different amounts in the culture supernatants of the wild type and ΔsecDF mutant (P-value <0.005).
| WT | Δ | ||||||||
| # | Identified Proteins | Localization | locus tag | Uniprot Acc.Nr. | MW (kDa) | NSAF | stdev | NSAF avg | stdev |
|
| |||||||||
| 1 | Cytotoxin K | EC | BC_1110 | Q81GS6 | 37 |
| 0.01 |
| |
| 2 | Enterotoxin/cell-wall binding protein EntB | EC | BC_2952 | Q81C32 | 55 |
| 0.004 |
| 0.001 |
| 3 | Perfringolysin O | EC | BC_5101 | Q815P0 | 57 |
| 0.001 |
| |
| 4 | Phospholipase C | EC | BC_0670 | Q81HW1 | 32 |
| 0.12 |
| |
| 5 | Non-hemolytic enterotoxin NheB | EC | BC_1810 | Q81EZ7 | 43 |
| 0.05 |
| 0.01 |
| 6 | Putative murein endopeptidase | U | BC_1991 | Q81EI5 | 44 |
| 0.007 |
| |
| 7 | Hemolysin BL lytic component L1 | EC | BC_3103 | Q7BYC6 | 44 |
| 0.05 |
| 0.01 |
| 8 | Hemolysin BL lytic component L2 | EC | BC_3104 | Q81BP7 | 49 |
| 0.08 |
| 0.003 |
| 9 | Sphingomyelin phosphodiesterase | EC | BC_0671 | Q81HW0 | 37 |
| 0.11 |
| |
| 10 | putative murein endopeptidase | CW | BC_0991 | Q81H34 | 65 |
| 0.001 |
| |
| 11 | Cell wall endopeptidase, family M23/M37 | EC | BC_0740 | Q81HR4 | 42 |
| 0.006 |
| 0.002 |
| 12 | Hemolysin BL binding component | EC | BC_3102 | Q81BP9 | 42 |
| 0.05 |
| |
| 13 | Microbial collagenase | EC | BC_0556 | Q81I63 | 109 |
| 0.039 |
| 0.005 |
| 14 | Bacillolysin | EC | BC_5351 | Q814S1 | 65 |
| 0.013 |
| 0.006 |
| 15 | Non-hemolytic enterotoxin NheA | EC | BC_1809 | Q81EZ8 | 44 |
| 0.05 |
| 0.01 |
| 16 | Flagellin | EC | BC_1657-9 | Q81FD3-5 | 29 |
| 0.08 |
| 0.10 |
|
| |||||||||
| 1 | DNA-binding protein HU | C | BC_3728 | Q81A62 | 10 |
| 0.02 |
| 0.02 |
| 2 | Foldase protein PrsA 1 | M | BC_1043 | PRSA1_BACCR | 32 |
|
| 0.002 | |
| 3 | 3-oxoacyl-[acyl-carrier-protein] synthase 2 | M | BC_1174 | Q81GL9 | 44 |
|
| 0.001 | |
| 4 | 50S ribosomal protein L10 | C | BC_0119 | RL10_BACCR | 18 |
| 0.006 |
| 0.011 |
| 5 | 30S ribosomal protein S10 | C | BC_0130 | RS10_BACCR | 12 |
| 0.016 |
| 0.029 |
| 6 | DNA-binding protein HU | C | BC_1510 | Q81FQ9 | 12 |
| 0.09 |
| 0.05 |
| 7 | Elongation factor G | C | BC_0128 | EFG_BACCR | 76 |
| 0.010 |
| 0.005 |
| 8 | 30S ribosomal protein S11 | C | BC_0157 | RS11_BACCR | 14 |
| 0.009 |
| 0.023 |
| 9 | Putative triosephosphate isomerase | C | BC_5137 | TPIS_BACCR | 26 |
| 0.009 |
| 0.019 |
| 10 | 50S ribosomal protein L6 | C | BC_0146 | RL6_BACCR | 20 |
| 0.004 |
| 0.028 |
| 11 | Putative uncharacterized protein | U | BC_p0002 | Q814F0 | 18 |
| 0.02 |
| 0.12 |
| 12 | 50S ribosomal protein L1 | C | BC_0118 | RL1_BACCR | 25 |
| 0.009 |
| 0.019 |
| 13 | 50S ribosomal protein L3 | C | BC_0131 | RL3_BACCR | 23 |
| 0.002 |
| 0.009 |
| 14 | 50S ribosomal protein L15 | C | BC_0150 | RL15_BACCR | 15 |
| 0.005 |
| 0.011 |
| 15 | Fructose-bisphosphate aldolase | C | BC_5335 | Q814T5 | 31 |
| 0.008 |
| 0.010 |
| 16 | 50S ribosomal protein L21 | C | BC_4438 | RL21_BACCR | 11 |
| 0.070 |
| 0.032 |
| 17 | 50S ribosomal protein L4 | C | BC_0132 | RL4_BACCR | 23 |
| 0.007 |
| 0.006 |
| 18 | 30S ribosomal protein S15 | C | BC_3806 | RS15_BACCR | 11 |
| 0.014 |
| 0.022 |
according to prediction of PSORTb algorithm (version 3.0.2; [26]): EC extracellular, C cytoplasmic, U unknown, M membrane; references for experimentally defined locations are given for proteins with predicted unknown localization.
Normalized Spectral Abundance Factor, mean average of three biological replicates; the NSAF normalizes across samples and takes protein sizes into account; values range between 0 and 1, increasing values indicate higher abundance [27], stdev standard deviation of the means of three biological replicates; probability ranges associated with Students t-test (Scaffold 4.0.5).
ND not detected (NSAF 0 in at least two biological replicates and <0.005).
*due to high sequence similarity all peptide hits for “flagellin” (Q81FD3, Q81FD4, Q81FD5) were combined.
Figure 4Comparison of NheA, NheB, Hbl_L1 and Hbl_L2 secretion by western-blot analysis.
Western-blot assay of secreted (left) and cell associated (right) toxin components NheA, NheB, Hbl_L1 and Hbl_L2. Samples of the growth medium were taken from the wild type (WT) and the ΔsecDF mutant (Δ) from 3 h (exponential phase), 4 h (transition phase) and 6 h (stationary phase) cultures with and without added glucose. The blots are representative of at least two biological replicates. To visualize size differences between pre- and mature proteins, a supernatant wild type sample (SN6H) has also been applied to the blot showing cell associated protein.
Figure 5Reduced PC-PLC activity in the ΔsecDF mutant.
A PC-PLC activity assay indicates reduced enzyme activity in the ΔsecDF mutant compared to the wild type strain. A) Filter-sterilized supernatant of cultures grown in LB (no glucose) or LBG (1% glucose) were assayed in a 2% egg-yolk solution. The results are the mean values of two independent experiments, and error bars represent standard deviations. B) Five µl of filter-sterilized supernatant of cultures grown in LB or LBG were spotted on 1% egg yolk agar plates. t0 marks the transition point of growth into stationary phase, and tn is the number of hours before (-) or after t0. The pictures represent one of two independent experiments.
Role of SecDF in virulence against Galleria mellonella insect larvae.
| Oral force feeding | Hemocoel injection | |||||||
| Hours post infection | 24 h | 72 h | 24 h | 72 h | ||||
| Strain | WT | Δ | WT | Δ | WT | Δ | WT | Δ |
|
|
|
|
|
|
|
|
|
|
|
| 0.1x106 | 20.4x106 | 0.2x106 | 13.3x106 | 1.4x104 | 8.2x104 | 0.09x104 | 3.3x104 |
| UDL cfu | 3.1x106 | 31.6x106 | 3.6x106 | 28.7x106 | 4.9x104 | 11.6x104 | 2.5x104 | 5.9x104 |
|
|
|
|
|
| ||||
Infections with mid log phase (OD600nm = 1) vegetative bacteria cultured in LB medium.
For oral infection the bacteria are mixed with 3 µg/10 µl of Cry1C toxin. The toxin alone results in ≈10% mortality.
LC50, correspond to the bacterial dose (cfu, colony forming units) per larvae, killing 50% of the treated larvae.
confidence interval at 95% level.
*(P-value ≤0.05). LDL (lower dose limit), UDL (upper dose limit). Mortality was estimated by Probit analysis (StatPlus). based on at least two independent experiments. Control experiments were run with buffer (PBS) and no mortality occurred within 72 hours at 37°C.
Genes with at least a five-fold differential transcription level in the ΔsecDF mutant compared to the isogenic wild type strain B. cereus ATCC 14579.
| Locus_tag | Genbank_annotation | FC | P–value | |
|
| BC2984 | Immune inhibitor A precursor | 9.79 | 2.9E-07 |
| BC2985 | Vancomycin B-type resistance protein vanW | 8.63 | 1.6E-06 | |
|
| BC0816 | periplasmic component of efflux system | 5.01 | 2.9E-07 |
| BC3586 | Oligopeptide-binding protein oppA | 0.18 | 2.7E-03 | |
| BC3788 | Nucleoside transport system permease protein | 0.06 | 2.9E-07 | |
| BC3790 | Nucleoside transport ATP-binding protein | 0.11 | 3.5E-05 | |
| BC3791 | Nucleoside-binding protein | 0.06 | 1.7E-06 | |
| BC3792 | Transcriptional regulator, GntR family | 0.09 | 1.4E-05 | |
|
|
| 0.13 | 1.0E-05 | |
| BC4831 | ABC transporter ATP-binding protein | 6.68 | 3.9E-08 | |
| BC5117 | ABC transporter permease protein | 0.11 | 1.6E-06 | |
| BC5118 | ABC transporter ATP-binding protein | 0.12 | 3.1E-05 | |
| BC5253 | ABC transporter permease protein | 0.08 | 9.1E-06 | |
| BC5254 | ABC transporter ATP-binding protein | 0.11 | 5.0E-06 | |
| BC5255 | periplasmic component of efflux system | 0.08 | 8.2E-07 | |
|
| BC0297 | Guanine-hypoxanthine permease | 0.08 | 9.2E-08 |
| BC0323 | PRAI carboxylase catalytic subunit | 0.04 | 2.4E-08 | |
| BC0324 | PRAI carboxylase ATPase subunit | 0.07 | 2.1E-08 | |
| BC0325 | Adenylosuccinate lyase | 0.07 | 3.7E-07 | |
| BC0326 | PRAI-succinocarboxamide synthase | 0.04 | 2.4E-05 | |
| BC0327 | PRFGA synthetase, PurS component | 0.04 | 4.6E-06 | |
| BC0328 | PRFGA synthase | 0.04 | 1.9E-06 | |
| BC0329 | PRFGA synthase | 0.04 | 1.6E-06 | |
| BC0330 | Amidophosphoribosyltransferase | 0.04 | 4.8E-06 | |
| BC0331 | PRFGA cyclo-ligase | 0.04 | 6.2E-07 | |
| BC0332 | Phosphoribosylglycinamide formyltransferase | 0.05 | 1.6E-06 | |
| BC0333 | IMP cyclohydrolase | 0.06 | 6.1E-06 | |
| BC0491 | Formate acetyltransferase | 0.18 | 2.1E-04 | |
| BC0492 | Pyruvate formate-lyase activating enzyme | 0.15 | 7.7E-04 | |
|
| BC1939 | Cytochrome d ubiquinol oxidase subunit II | 6.31 | 2.3E-05 |
| BC2119 | Respiratory nitrate reductase beta chain | 0.07 | 2.2E-04 | |
| BC2120 | Respiratory nitrate reductase delta chain | 0.20 | 3.2E-02 | |
| BC4792 | Cytochrome d ubiquinol oxidase subunit I | 0.14 | 8.6E-05 | |
| BC4793 | Cytochrome d ubiquinol oxidase subunit II | 0.11 | 8.1E-04 | |
|
| BC0813 | enterotoxin/cell-wall binding protein entC | 6.35 | 6.3E-07 |
| BC1435 | hypothetical protein | 33.96 | 2.1E-08 | |
| BC1436 | Phage shock protein A | 12.83 | 7.9E-07 | |
| BC5239 | enterotoxin/cell-wall binding protein entA | 5.60 | 7.9E-07 | |
| BC5361 | ECF-type sigma factor negative effector | 12.40 | 1.7E-06 | |
| BC5362 | ECF-type sigma factor negative effector | 8.26 | 2.4E-08 | |
| BC5363 | RNA polymerase ECF-type sigma factor | 16.82 | 4.8E-07 | |
|
| BC1657 | Flagellin | 0.18 | 1.8E-06 |
| BC1659 | Flagellin | 0.19 | 6.7E-05 | |
|
| BC0862 | Protease I | 15.77 | 1.3E-05 |
| BC0863 | Catalase | 13.31 | 4.2E-06 | |
| BC0998 | General stress protein 17M | 11.41 | 2.1E-08 | |
| BC0999 | hypothetical protein | 12.27 | 2.8E-07 | |
| BC1000 | hypothetical Membrane Spanning Protein | 12.54 | 6.7E-06 | |
| BC1002 | Anti-sigma B factor antagonist | 5.36 | 2.5E-06 | |
| BC1003 | Anti-sigma B factor | 8.97 | 1.4E-06 | |
| BC1004 | RNA polymerase sigma-B factor | 7.84 | 1.8E-06 | |
| BC1010 | hypothetical protein | 10.61 | 4.5E-06 | |
| BC3130 | hypothetical protein | 5.30 | 7.4E-05 | |
|
| BC0494 | hypothetical Cytosolic Protein | 0.19 | 6.7E-06 |
| BC1760 | 3-oxoacyl-[acyl-carrier-protein] synthase III | 5.06 | 2.6E-06 | |
| BC1852 | Exonuclease SbcC | 0.20 | 3.4E-04 | |
| BC1854 | hypothetical Cytosolic Protein | 0.20 | 1.4E-04 | |
| BC1861 | DNA/RNA helicase (DEAD/DEAH box family) | 0.20 | 3.2E-05 | |
| BC2056 | hypothetical protein | 0.16 | 3.4E-07 | |
| BC4482 | hypothetical protein | 5.32 | 6.5E-05 | |
| BC4813 | hypothetical protein | 14.25 | 1.8E-07 | |
| BC5116 | hypothetical protein | 0.16 | 1.3E-05 | |
| BC5119 | hypothetical protein | 0.12 | 2.8E-05 | |
| BC5120 | hypothetical Cytosolic Protein | 0.12 | 6.7E-06 | |
| BC5121 | hypothetical protein | 0.12 | 1.7E-05 | |
| BC5122 | hypothetical Cytosolic Protein | 0.18 | 2.4E-05 | |
| BC5123 | hypothetical protein | 0.16 | 3.6E-05 | |
| BC5124 | hypothetical protein | 0.19 | 2.7E-05 | |
| BC5243 | hypothetical protein | 0.20 | 9.1E-05 | |
| BC5252 | hypothetical Membrane Spanning Protein | 0.11 | 2.3E-06 |
data on the linear plasmid pBClin15 can be found in the supplementary file.
FC fold change of transcriptional expression in B. cereus ΔsecDF compared to wild type.
P-values were computed using false discovery rate correction of 0.05 by an Bayesisn linear model as integrated in the Limma-package [90]; data represent six independent cultures.
purine operon under the control of PurA.